EUVIMEDEUVIMED entdecken
Fallbericht

ROTEM could be useful for lupus anticoagulant hypoprothrombinemia syndrome

Koyo Yamada, Yuto Nakajima iD, Kenichi Ogiwara, Toshiyuki Sakai, Kazuyoshi Fukuda, Keiji Nogami iD

Pediatrics International · 2024

DOI: 10.1111/ped.15773 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Pediatrics International, 2024. Verfasst von Koyo Yamada und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan. Hauptthemen laut MEDLINE: Hypoprothrombinemias, Lupus Coagulation Inhibitor, Thrombelastography. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 32 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Lupus anticoagulant‐hypoprothrombinemia syndrome (LAHPS) is a rare disease caused by acquired factor II (FII) deficiency and lupus anticoagulant. Patients with LAHPS typically present with thrombosis and bleeding. However, little information is available on the evaluation of coagulation potential in patients with LAHPS. We examined global coagulation potentials in patients with LAHPS during the clinical course in this study.

Methods

Coagulation potentials in two pediatric patients with LAHPS were assessed by measuring clotting time (CT) and clot formation time using Ca 2+ ‐triggered rotational thromboelastometry (ROTEM), CT and maximum coagulation velocity using clot waveform analysis (CWA), and lag time and peak thrombin using the thrombin generation assay (TGA). The day of admission was defined as day 0.

Results

In case 1, the bleeding symptoms disappeared by day 5. However, the TGA and CWA results were markedly lower than normal, although FII activity (FII:C) returned to within the normal range by day 14. In contrast, ROTEM revealed a recovery to near‐normal levels (day 14). All coagulation parameters (day 80) were within normal ranges. In case 2, coagulation potential was severely depressed until day 12, although FII:C returned to normal levels. Bleeding symptoms disappeared on day 19, and the ROTEM data revealed that the parameters were close to the normal range. The coagulation parameters in all assays were normalized on day 75.

Conclusions

Recovery of coagulation potential in patients with LAHPS was slower than the recovery of FII:C. Moreover, ROTEM appeared to be clinically useful for assessing coagulation potential in patients with LAHPS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypoprothrombinemiasLupus Coagulation InhibitorThrombelastographyHumansFemaleMaleChildBlood Coagulation TestsBlood CoagulationChild, PreschoolAntiphospholipid Syndrome

Stichwörter der Autor:innen

bleeding complicationchildrenglobal coagulation potentiallupus anticoagulant‐hypoprothrombinemia syndromethrombosis

Substanzen

Lupus Coagulation Inhibitor

Autor:innen und Institutionen

  • Department of Pediatrics, Nara Medical University, Kashihara, Nara, Japan.
  • Pediatrics, Kokuho Central Hospital, Tawaramoto, Nara, Japan.
  • Advanced Medical Science of Thrombosis and Hemostasis, Nara Medical University, Kashihara, Nara, Japan.
  • Pediatrics, Saiseikai Chuwa Hospital, Sakurai, Nara, Japan.

ORCID-Profile: Yuto Nakajima, Keiji Nogami

Zitieren

APA

Yamada, K., Nakajima, Y., Ogiwara, K., Sakai, T., Fukuda, K., & Nogami, K. (2024). ROTEM could be useful for lupus anticoagulant hypoprothrombinemia syndrome. Pediatrics International. https://doi.org/10.1111/ped.15773

Vancouver

Yamada K, Nakajima Y, Ogiwara K, Sakai T, Fukuda K, Nogami K. ROTEM could be useful for lupus anticoagulant hypoprothrombinemia syndrome. Pediatrics International. 2024. doi:10.1111/ped.15773

BibTeX
@article{Yamada2024,
  author = {Yamada, Koyo and Nakajima, Yuto and Ogiwara, Kenichi and Sakai, Toshiyuki and Fukuda, Kazuyoshi and Nogami, Keiji},
  title = {ROTEM could be useful for lupus anticoagulant hypoprothrombinemia syndrome},
  journal = {Pediatrics International},
  year = {2024},
  doi = {10.1111/ped.15773}
}
Kostenlos starten →